Mepenzolate bromide - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for mepenzolate bromide and what is the scope of patent protection?
Mepenzolate bromide
is the generic ingredient in one branded drug marketed by Sanofi Aventis Us and is included in one NDA. Additional information is available in the individual branded drug profile pages.There is one drug master file entry for mepenzolate bromide.
Summary for mepenzolate bromide
US Patents: | 0 |
Tradenames: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Drug Master File Entries: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 66 |
Patent Applications: | 3,402 |
DailyMed Link: | mepenzolate bromide at DailyMed |
US Patents and Regulatory Information for mepenzolate bromide
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sanofi Aventis Us | CANTIL | mepenzolate bromide | SOLUTION;ORAL | 010679-004 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Sanofi Aventis Us | CANTIL | mepenzolate bromide | TABLET;ORAL | 010679-003 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |